GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bactiguard Holding AB (OSTO:BACTI B) » Definitions » Research & Development

Bactiguard Holding AB (OSTO:BACTI B) Research & Development : kr0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Bactiguard Holding AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bactiguard Holding AB's Research & Development for the three months ended in Mar. 2025 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.0 Mil.


Bactiguard Holding AB Research & Development Historical Data

The historical data trend for Bactiguard Holding AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bactiguard Holding AB Research & Development Chart

Bactiguard Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bactiguard Holding AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bactiguard Holding AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bactiguard Holding AB  (OSTO:BACTI B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Bactiguard Holding AB Research & Development Related Terms

Thank you for viewing the detailed overview of Bactiguard Holding AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Bactiguard Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Vasagatan 11, 2nd Floor, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Bactiguard Holding AB Headlines

No Headlines